Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.28 -0.03 (-8.19%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Accumulated Depreciation (2013 - 2020)

Updated

Vistagen Therapeutics (VTGN) posted Accumulated Depreciation of $1.04 million for fiscal Q4 2020 (quarter ended Mar 31, 2020), up 11.0% from $933,400 a year earlier.

Analysis

Vistagen Therapeutics (VTGN) Accumulated Depreciation (2013 - 2020) Analysis & Trends

Since fiscal Q4 2013, Vistagen Therapeutics has reported Accumulated Depreciation for 6 quarters.

  • Annual Accumulated Depreciation shows a five-year compound annual growth rate of 9.3% (FY2015 to FY2020).
  • In prior fiscal years, Vistagen Therapeutics' Accumulated Depreciation was $933,400 in FY2019 and $711,000 in FY2016 (+6.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 1.04 Mn
Mar 31, 2019 933,400.00
Mar 31, 2016 711,000.00
Mar 31, 2015 665,100.00
Mar 31, 2014 -605,900.00
Mar 31, 2013 -551,300.00
API Access

Vistagen Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=VTGN&period=max&api_key=YOUR_API_KEY